Doxycycline Compared with Benzathine Penicillin for the Treatment of Early Syphilis | Zendy

Khalil G. Ghanem | Zendy; Emily J. Erbelding | Zendy; Wu Cheng | Zendy; Anne Rompalo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Doxycycline Compared with Benzathine Penicillin for the Treatment of Early Syphilis

Author(s) -

Khalil G. Ghanem,

Emily J. Erbelding,

Wu Cheng,

Anne Rompalo

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/500406

Subject(s) - medicine , rapid plasma reagin , doxycycline , syphilis , serology , titer , penicillin , congenital syphilis , surgery , pediatrics , immunology , antibiotics , antibody , treponema , human immunodeficiency virus (hiv) , microbiology and biotechnology , biology

Doxycycline is the preferred recommended second-line agent for the treatment of syphilis, although efficacy data from controlled trials are lacking. We compared the serological responses of patients with early syphilis treated with doxycycline with the responses of patients treated with benzathine penicillin G (BPG).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research